TabsDetailsBasic DetailsDate Posted: Friday, June 3, 2016Status: CompleteMedical Product: fenofibrate, niacin, statinDescription: Modular program-based one-time assessment of concomitant use of niacin and statins and concomitant use of fenofibrates and statins. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2000 to May 31, 2013. Modular programs are adaptable standardized programs. Results were generated using Modular Program 4; click here for more information. Queries were distributed in March 2014. If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org. The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer. Read More Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - May 31,2013Study Type: Modular ProgramAssessment Type: Exploratory AnalysesData Sources: Mini-Sentinel Distributed Database (MSDD)Related Links: Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 ProductsSafety Assessment of Niacin in the U.S. Food and Drug Administration's Mini-Sentinel SystemNiacin and Fenofibrate Use and Outcomes with Propensity Score Matching